ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis

R. Deng, B. Huang, Y. Shi, Y. Ma.

Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Meeting: 2018 American Transplant Congress

Abstract number: C246

Keywords: Graft failure, Mortality, Pulmonary hypertension

Session Information

Date: Monday, June 4, 2018

Session Name: Poster Session C: Liver: Recipient Selection

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Related Abstracts
  • Pulmonary Hypertension in Renal Transplant Candidates: A Systematic Review and Meta-Analysis of the Available Evidence.
  • Evaluation the Outcomes of Liver Transplant Recipients Underwent Splenectomy: A Meta-Analysis

Background: Portopulmonary hypertension(PPH) was once regarded as a contraindicaton in liver transplantation(LT).However,growing evidence indicated that PPH patients underwent LT may show similar outcomes compared to those with other symptoms and researchers recommended it not be an absolute contraindication. Given the current controversy, we aimed to identify, appraise, and synthesize the current evidence comparing the prognosis after LT between candidates with PPH and those not.

Methods: We systematically searched for all studies that compared the outcomes of PPH patients and those not. The MEDLINE, EMBASE and Cochrane Library databases were searched. All studies reporting outcomes of initial PPH patients versus those not(Control)were further considered for inclusion in this meta-analysis. Odds ratios and 95% confidence intervals (CI) were calculated to compare the pooled data between PPH and Control groups.

Results: Twelve retrospective and one prospective, randomized, controlled trials, involving 37729 transplant recipients, were included. Initial PPH transplant recipients both had an increased 1-year mortality with an odds ratio of 1.68(95% CI = 1.33–2.11,P<0.0001) compared to Control. Additionally, higher graft lost rate also appeared in PPH groups(OR=1.77 (95% CI = 1.26–2.50,P=0.001).However, no significant difference was seen between the two groups in 30-day mortality.

Conclusion: Patients underwent LT with initial PPH had increased 1-year mortality and graft loss rates compared to those who did not have pulmonary symptoms, the diffrence may be non-significant in the early period post-LT. Nevertheless, LT may be a therapeutic option to PPH patients, which could reduce the mortality of PPH patients.

CITATION INFORMATION: Deng R., Huang B., Shi Y., Ma Y. The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Deng R, Huang B, Shi Y, Ma Y. The Outcomes of Candidates Underwent Liver Transplantaion with Portopulmonary Hypertension: A Meta-Analysis [abstract]. https://atcmeetingabstracts.com/abstract/the-outcomes-of-candidates-underwent-liver-transplantaion-with-portopulmonary-hypertension-a-meta-analysis/. Accessed March 8, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Search
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.